Nykode Therapeutics AS (NYKD.OL)

NOK 2.47

(-0.72%)

Revenue Summary of Nykode Therapeutics AS

  • Nykode Therapeutics AS's latest annual revenue in 2023 was 12.9 Million USD , up 97.76% from previous year.
  • Nykode Therapeutics AS's latest quarterly revenue in 2024 Q2 was 544 Thousand USD , down -34.22% from previous quarter.
  • Nykode Therapeutics AS reported a annual revenue of 68.96 Million USD in annual revenue 2022, down -76.39% from previous year.
  • Nykode Therapeutics AS reported a annual revenue of 292.03 Million USD in annual revenue 2021, down -85.57% from previous year.
  • Nykode Therapeutics AS reported a quarterly revenue of 8.7 Million USD for 2024 Q1, down -58.98% from previous quarter.
  • Nykode Therapeutics AS reported a quarterly revenue of 136.38 Million USD for 2023 FY, up 97.76% from previous quarter.

Annual Revenue Chart of Nykode Therapeutics AS (2023 - 2016)

Created with Highcharts 11.1.0YearsRevenue201620172018201920202021202220230 NOK500000000 NOK1000000000 NOK1500000000 NOK2000000000 NOK2500000000 NOK

Historical Annual Revenue of Nykode Therapeutics AS (2023 - 2016)

Year Revenue Revenue Growth
2023 12.9 Million USD 97.76%
2022 68.96 Million USD -76.39%
2021 292.03 Million USD -85.57%
2020 2.02 Billion USD 0.0%
2019 - USD -100.0%
2018 129 Thousand NOK -73.47%
2017 486.18 Thousand NOK 99.95%
2016 243.14 Thousand NOK 0.0%

Peer Revenue Comparison of Nykode Therapeutics AS

Name Revenue Revenue Difference
Arctic Bioscience AS 33.75 Million NOK 61.772%
Aqua Bio Technology ASA 1.55 Million NOK -727.209%
ArcticZymes Technologies ASA 118.93 Million NOK 89.152%
BerGenBio ASA 354 Thousand NOK -3544.633%
Hofseth BioCare ASA 194.87 Million NOK 93.379%
PCI Biotech Holding ASA 2.99 Million NOK -331.505%
Thor Medical ASA - NOK -Infinity%
Ultimovacs ASA - NOK -Infinity%